SCHEMBL29908262

SCHEMBL29908262

C(#Cc1ccnc(-c2ccnc(N3CCN(c4ccccc4)CC3)n2)n1)c1ccc2[nH]ncc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 8/20 0.39
ROCK1 Q13464 3/20 0.39
GRIN1 Q05586 2/20 0.39
GRIN2B Q13224 2/20 0.39
PIK3CA P42336 1/20 0.38
MAPT P10636 4/20 0.38
TSHR P16473 2/20 0.38
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CYP3A4 P08684 2/20 0.37
LMNA P02545 2/20 0.37
DRD2 P14416 1/20 0.37
DRD4 P21917 1/20 0.37
DRD3 P35462 1/20 0.37
HTR1A P08908 1/20 0.36
WEE1 P30291 1/20 0.35
ALK Q9UM73 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29627924 0.91 PIK3CA (0.40) ROCK2ROCK1PIK3CACYP3A4HTR1A
SCHEMBL29908225 0.91 KCNH2 (0.43) ROCK2ROCK1CYP3A4DRD2DRD4
SCHEMBL29908257 0.91 GRIN2B (0.41) ROCK2ROCK1GRIN2BPIK3CAMAPT
SCHEMBL29627883 0.88 ACACB (0.46) ROCK2ROCK1GRIN1GRIN2BPIK3CA
SCHEMBL29640905 0.88 GAA (0.41) ROCK2ROCK1GRIN1GRIN2BPIK3CA
SCHEMBL29627719 0.87 ROCK2 (0.53) ROCK2ROCK1GRIN1GRIN2B
SCHEMBL29627972 0.86 ROCK2 (0.38) ROCK2ROCK1GRIN1GRIN2BHTR1A
SCHEMBL29627894 0.85 ROCK2 (0.39) ROCK2ROCK1GRIN1GRIN2BHTR1A
SCHEMBL29908258 0.85 ROCK2 (0.44) ROCK2ROCK1GRIN1GRIN2B
SCHEMBL29627923 0.83 ROCK2 (0.45) ROCK2ROCK1WEE1ALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220281841-A1 ETHYNYLHETEROCYCLES AS RHO-ASSOCIATED COILED-COIL KINASE (ROCK) INHIBITORS ANGION BIOMEDICA CORP. 2022-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220281841-A1 ETHYNYLHETEROCYCLES AS RHO-ASSOCIATED COILED-COIL KINASE (ROCK) INHIBITORS ROCK1, ROCK2, CIT ROCK2 2/4885ROCK1 1/4885GRIN1 4062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.